Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders

The Pharmacogenomics Journal volume 2, pages 217–235 (2002)Cite this article

Abstract

The norepinephrine, dopamine and serotonin transporters (NET, DAT and SERT, respectively), limit cellular signaling by recapturing released neurotransmitter, and serve as targets for antidepressants and drugs of abuse, emphasizing the integral role these molecules play in neurotransmission and pathology. This has compelled researchers to search for polymorphisms in monoamine (MA) transporter genes. Studies support linkage and association of MA transporter genetic variation in psychiatric and other complex disorders. Understanding the contribution of MA transporter polymorphisms to human behavior, disease susceptibility and response to pharmacotherapies will involve further progress in linkage and association that will be aided by both definition of highly selective phenotypes and utilization of a large number of polymorphic markers. The relationship of polymorphisms to alterations in transport capacity, likely a complex interaction, involving genetic background, disease state, and medication, will elucidate the means by which MA transporter genetic variability contributes to our individuality.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Notes

  1. We refer to serotonin transporter cDNA and protein with the acronym SERT and the cognate gene with the acronym 5-HTT, the latter proposed by Lesch and co-workers.

References

  1. Schildkraut JJ . The catecholamine hypothesis of affective disorders: a review of supporting evidence Am J Psychiatry 1965 122: 509–522

    Article  CAS  PubMed  Google Scholar 

  2. Ressler KJ, Nemeroff CB . Role of norepinephrine in the pathophysiology and treatment of mood disorders Biol Psychiatry 1999 46: 1219–1233

    Article  CAS  PubMed  Google Scholar 

  3. Leonard BE . The role of noradrenaline in depression: a review J Psychopharmacol 1997 11: S39–S47

    CAS  PubMed  Google Scholar 

  4. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA . Reduced levels of norepinephrine transporters in the locus coeruleus in major depression J Neurosci 1997 17: 8451–8458

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bohm M, La Rosee K, Schwinger RH, Erdmann E . Evidence for reduction of norepinephrine uptake sites in the failing human heart J Am Coll Cardiol 1995 25: 146–153

    Article  CAS  PubMed  Google Scholar 

  6. Liang CS, Fan TH, Sullebarger JT, Sakamoto S . Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation J Clin Invest 1989 84: 1267–1275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Merlet P, Dubois-Rande JL, Adnot S, Bourguignon MH, Benvenuti C, Loisance D et al . Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy J Cardiovasc Pharmacol 1992 19: 10–16

    Article  CAS  PubMed  Google Scholar 

  8. Schafers M, Dutka D, Rhodes CG, Lammertsma AA, Hermansen F, Schober O, Camici PG . Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy Circ Res 1998 82: 57–62

    Article  CAS  PubMed  Google Scholar 

  9. Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H et al . Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients Hypertension 1981 3: 149–156

    Article  CAS  PubMed  Google Scholar 

  10. Imamura M, Lander HM, Levi R . Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1-receptors and alpha2-adrenoceptors Circ Res 1996 78: 475–481

    Article  CAS  PubMed  Google Scholar 

  11. Koob GF, Sanna PP, Bloom FE . Neuroscience of addiction Neuron 1998 21: 467–476

    Article  CAS  PubMed  Google Scholar 

  12. Carlsson A . Perspectives on the discovery of central monoaminergic neurotransmission Annu Rev Neurosci 1987 10: 19–40

    Article  CAS  PubMed  Google Scholar 

  13. Bannon MJ, Granneman JG, Kapatos G . The Dopamine Transporter. Potential involvement in neuropsychiatric disorders In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the Fourth Generation of Progress Raven Press: New York 1995 pp 179–187

    Google Scholar 

  14. Coccaro EF . Central serotonin and impulsive aggression Br J Psychiatry Suppl 1989 8: 52–62

    Article  Google Scholar 

  15. Owens MJ, Nemeroff CB . Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter Clin Chem 1994 40: 288–295

    CAS  PubMed  Google Scholar 

  16. Sellers EM, Higgins GA, Sobell MB . 5-HT and alcohol abuse Trends Pharmacol Sci 1992 13: 69–75

    Article  CAS  PubMed  Google Scholar 

  17. Ernouf D, Compagnon P, Lothion P, Narcisse G, Benard JY, Daoust M . Platelets 3H 5-HT uptake in descendants from alcoholic patients: a potential risk factor for alcohol dependence? Life Sci 1993 52: 989–995

    Article  CAS  PubMed  Google Scholar 

  18. Barker EL, Blakely RD . Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs. In: Bloom FE, Kupfer DJ, (eds). Psychopharmacology: the Fourth Generation of Progress Raven Press: New York 1995

    Google Scholar 

  19. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 1996 379: 606–612

    Article  CAS  PubMed  Google Scholar 

  20. Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW et al . Mice lacking the norepinephrine transporter are supersensitive to psychostimulants Nature Neurosci 2000 3: 465–471

    Article  CAS  PubMed  Google Scholar 

  21. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A et al . Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in serotonin transporter-deficient mice Mol Pharmacol 1998 53: 649–655

    Article  CAS  PubMed  Google Scholar 

  22. Amara SG, Kuhar MJ . Neurotransmitter transporters: recent progress Annu Rev Neurosci 1993 16: 73–93

    Article  CAS  PubMed  Google Scholar 

  23. Melikian HE, McDonald JK, Gu H, Rudnick G, Moore KR, Blakely RD . Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody J Biol Chem 1994 269: 12290–12297

    CAS  PubMed  Google Scholar 

  24. Melikian HE, Ramamoorthy S, Tate CG, Blakely RD . Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition Mol Pharmacol 1996 50: 266–276

    CAS  PubMed  Google Scholar 

  25. Ramamoorthy S, Blakely RD . Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants Science 1999 285: 763–766

    Article  CAS  PubMed  Google Scholar 

  26. Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, Blakely RD . Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A J Neurosci 2000 20: 7571–7578

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD . Acute regulation of norepinephrine transport: I. protein kinase C- linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells J Pharmacol Exp Ther 1998 287: 733–743

    CAS  PubMed  Google Scholar 

  28. Apparsundaram S, Schroeter S, Giovanetti E, Blakely RD . Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins J Pharmacol Exp Ther 1998 287: 744–751

    CAS  PubMed  Google Scholar 

  29. Vaughan RA, Huff RA, Uhl GR, Kuhar MJ . Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes J Biol Chem 1997 272: 15541–15546

    Article  CAS  PubMed  Google Scholar 

  30. Chang MY, Lee SH, Kim JH, Lee KH, Kim YS, Son H, Lee YS . Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein J Neurochem 2001 77: 754–761

    Article  CAS  PubMed  Google Scholar 

  31. Gelernter J, Kruger S, Pakstis AJ, Pacholczyk T, Sparkes RS, Kidd KK, Amara S . Assignment of the norepinephrine transporter protein (NET1) locus to chromosome 16 Genomics 1993 18: 690–692

    Article  CAS  PubMed  Google Scholar 

  32. Brüss M, Kunz J, Lingen B, Bönisch H . Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter Hum Genet 1993 91: 278–280

    Article  PubMed  Google Scholar 

  33. Pörzgen P, Bönisch H, Brüss M . Molecular cloning and organization of the coding region of the human norepinephrine transporter gene [published erratum appears in Biochem Biophys Res Commun 1996 227: 642–643] Biochem Biophys Res Commun 1995 215: 1145–1150

    Article  PubMed  Google Scholar 

  34. Kim CH, Kim HS, Cubells JF, Kim KS . A previously undescribed intron and extensive 5′ upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene J Biol Chem 1999 274: 6507–6518

    Article  CAS  PubMed  Google Scholar 

  35. Meyer J, Wiedemann P, Okladnova O, Bruss M, Staab T, Stober G et al . Cloning and functional characterization of the human norepinephrine transporter gene promoter J Neural Transm 1998 105: 1341–1350

    Article  CAS  PubMed  Google Scholar 

  36. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR . Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR Genomics 1992 14: 1104–1106

    Article  CAS  PubMed  Google Scholar 

  37. Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG . Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter Mol Pharmacol 1992 42: 383–390

    CAS  PubMed  Google Scholar 

  38. Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD et al . Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations Mol Psychiatry 2000 5: 283–292

    Article  CAS  PubMed  Google Scholar 

  39. Kawarai T, Kawakami H, Yamamura Y, Nakamura S . Structure and organization of the gene encoding human dopamine transporter Gene 1997 195: 11–18

    Article  CAS  PubMed  Google Scholar 

  40. Donovan DM, Vandenbergh DJ, Perry MP, Bird GS, Ingersoll R, Nanthakumar E, Uhl GR . Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures Brain Res Mol Brain Res 1995 30: 327–335

    Article  CAS  PubMed  Google Scholar 

  41. Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U et al . Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene J Neural Transm Gen Sect 1995 102: 247–254

    Article  CAS  PubMed  Google Scholar 

  42. Gelernter J, Pakstis AJ, Kidd KK . Linkage mapping of serotonin transporter protein gene SLC6A4 on chromosome 17 Hum Genet 1995 95: 677–680

    Article  CAS  PubMed  Google Scholar 

  43. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS et al . Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization Proc Natl Acad Sci USA 1993 90: 2542–2546

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Hahn MK, Blakely RD . Gene organization and polymorphisms of monoamine transporters. Relationship to psychiatric and other complex diseases. In: Reith MEA (ed). Neurotransmitter Transporters. Structure, Function, and Regulation, 2nd edn. pp 111–169 Humana Press: Totowa 2002

    Book  Google Scholar 

  45. Pörzgen P, Bönisch H, Hammermann R, Brüss M . The human noradrenaline transporter gene contains multiple polyadenylation sites and two alternatively spliced C-terminal exons Biochim Biophys Acta 1998 1398: 365–370

    Article  PubMed  Google Scholar 

  46. Kitayama S, Morita K, Dohi T . Functional characterization of the splicing variants of human norepinephrine transporter Neurosci Lett 2001 312: 108–112

    Article  CAS  PubMed  Google Scholar 

  47. Torres GE, Yao W, Mohn AR, Quan H, Kim K, Levey AI et al . Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1 Neuron 2001 30: 121–134

    Article  CAS  PubMed  Google Scholar 

  48. Bradley CC, Blakely RD . Alternative splicing of the human serotonin transporter gene J Neurochem 1997 69: 1356–1367

    Article  CAS  PubMed  Google Scholar 

  49. Balser JR . Inherited sodium channelopathies, novel therapeutic and proarrhythmic molecular mechanisms Trends Cardiovasc Med 2001 11: 229–237

    Article  CAS  PubMed  Google Scholar 

  50. Liggett SB . Beta(2)-adrenergic receptor pharmacogenetics Am J Respir Crit Care Med 2000 161: S197–S201

    Article  CAS  PubMed  Google Scholar 

  51. Zhu MY, Blakely RD, Apparsundaram S, Ordway GA . Down-regulation of the human norepinephrine transporter in intact 293- hNET cells exposed to desipramine J Neurochem 1998 70: 1547–1555

    Article  CAS  PubMed  Google Scholar 

  52. Bernstein EM, Quick MW . Regulation of gamma-aminobutyric acid (GABA) transporters by extracellular GABA J Biol Chem 1999 274: 889–895

    Article  CAS  PubMed  Google Scholar 

  53. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD . Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression J Neurosci 1997 17: 45–57

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Daniels GM, Amara SG . Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters J Biol Chem 1999 274: 35794–35801

    Article  CAS  PubMed  Google Scholar 

  55. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN et al . Relationship between subjective effects of cocaine and dopamine transporter occupancy Nature 1997 386: 827–830

    Article  CAS  PubMed  Google Scholar 

  56. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D et al . Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am J Psychiatry 2001 158: 377–382

    Article  CAS  PubMed  Google Scholar 

  57. Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H et al . Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET Am J Psychiatry 2001 158: 1206–1214

    Article  CAS  PubMed  Google Scholar 

  58. Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al . Striatal dopamine nerve terminal markers in human, chronic methamphetamine users Nat Med 1996 2: 699–703

    Article  CAS  PubMed  Google Scholar 

  59. Blier P, de Montigny C . Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses Biol Psychiatry 1998 44: 313–323

    Article  CAS  PubMed  Google Scholar 

  60. Nelson JC . A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression Biol Psychiatry 1999 46: 1301–1308

    Article  CAS  PubMed  Google Scholar 

  61. Shelton RC, Tomarken AJ . Can recovery from depression be achieved? Psychiatr Serv 2001 52: 1469–1478

    Article  CAS  PubMed  Google Scholar 

  62. Gelernter J, Kruger S, Kidd KK, Amara S . TaqI RFLP at norepinephrine transporter protein (NET) locus Hum Mol Genet 1993 2: 820

    Article  CAS  PubMed  Google Scholar 

  63. Hadley D, Hoff M, Holik J, Reimherr F, Wender P, Coon H, Byerley W . Manic-depression and the norepinephrine transporter gene Hum Hered 1995 45: 165–168

    Article  CAS  PubMed  Google Scholar 

  64. Stöber G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M et al . Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders Am J Med Genet 1996 67: 523–532

    Article  PubMed  Google Scholar 

  65. Stöber G, Hebebrand J, Cichon S, Bruss M, Bonisch H, Lehmkuhl G et al . Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening Am J Med Genet 1999 88: 158–163

    Article  PubMed  Google Scholar 

  66. Owen D, Du L, Bakish D, Lapierre YD, Hrdina PD . Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression Psychiatry Res 1999 87: 1–5

    Article  CAS  PubMed  Google Scholar 

  67. Runkel F, Bruss M, Nothen MM, Stober G, Propping P, Bonisch H . Pharmacological properties of naturally occurring variants of the human norepinephrine transporter Pharmacogenetics 2000 10: 397–405

    Article  CAS  PubMed  Google Scholar 

  68. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A et al . Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis Nat Genet 1999 22: 239–247

    Article  CAS  PubMed  Google Scholar 

  69. Hahn MK, Mazei MS, Robertson D, Blakely RD . Role of human norepinephrine transporter gene single nucleotide polymorphisms in cardiovascular disease Am J Med Genet 2000 67(Suppl 2): 369

    Google Scholar 

  70. Robertson D . The epidemic of orthostatic tachycardia and orthostatic intolerance Am J Med Sci 1999 317: 75–77

    Article  CAS  PubMed  Google Scholar 

  71. Jacob G, Shannon JR, Costa F, Furlan R, Biaggioni I, Mosqueda-Garcia R et al . Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance Circulation 1999 99: 1706–1712

    Article  CAS  PubMed  Google Scholar 

  72. Eisenhofer G, Esler MD, Meredith IT, Dart A, Cannon ROD, Quyyumi AA et al . Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine Circulation 1992 85: 1775–1785

    Article  CAS  PubMed  Google Scholar 

  73. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I et al . Clues to the origin of orthostatic intolerance: a genetic defect in the cocaine- and antidepressant sensitive norepinephrine transporter New Engl J Med 2000 342: 541–549

    Article  CAS  PubMed  Google Scholar 

  74. Kilic F, Rudnick G . Oligomerization of serotonin transporter and its functional consequences Proc Natl Acad Sci USA 2000 97: 3106–3111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Hastrup H, Karlin A, Javitch JA . Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment Proc Natl Acad Sci 2001 98: 10055–10060

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Blakely RD . Physiological genomics of antidepressant targets: keeping the periphery in mind J Neurosci 2001 21: 8319–8323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Sano A, Kondoh K, Kakimoto Y, Kondo I . A 40-nucleotide repeat polymorphism in the human dopamine transporter gene Hum Genet 1993 91: 405–406

    Article  CAS  PubMed  Google Scholar 

  78. Gelernter J, Kranzler H, Lacobelle J . Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF)) Genomics 1998 52: 289–297

    Article  CAS  PubMed  Google Scholar 

  79. Kang AM, Palmatier MA, Kidd KK . Global variation of a 40-bp VNTR in the 3′-untranslated region of the dopamine transporter gene (SLC6A3) Biol Psychiatry 1999 46: 151–160

    Article  CAS  PubMed  Google Scholar 

  80. Mitchell RJ, Howlett S, Earl L, White NG, McComb J, Schanfield MS et al . Distribution of the 3′ VNTR polymorphism in the human dopamine transporter gene in world populations Hum Biol 2000 72: 295–304

    CAS  PubMed  Google Scholar 

  81. Vandenbergh DJ, Persico AM, Uhl GR . A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs Brain Res Mol Brain Res 1992 15: 161–166

    Article  CAS  PubMed  Google Scholar 

  82. Byerley W, Hoff M, Holik J, Caron MG, Giros B . VNTR polymorphism for the human dopamine transporter gene (DAT1) Hum Mol Genet 1993 2: 335

    Article  CAS  PubMed  Google Scholar 

  83. Cargill M et al . Characterization of single-nucleotide polymorphisms in coding regions of human genes Nat Genet 1999 22: 231–238

    Article  CAS  PubMed  Google Scholar 

  84. Grunhage F, Schulze TG, Muller DJ, Lanczik M, Franzek E, Albus M et al . Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1) Mol Psychiatry 2000 5: 275–282

    Article  CAS  PubMed  Google Scholar 

  85. Ueno S, Nakamura M, Mikami M, Kondoh K, Ishiguro H, Arinami T et al . Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism Mol Psychiatry 1999 4: 552–557

    Article  CAS  PubMed  Google Scholar 

  86. Morino H, Kawarai T, Izumi Y, Kazuta T, Oda M, Komure O et al . A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease Ann Neurol 2000 47: 528–531

    Article  CAS  PubMed  Google Scholar 

  87. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR . Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder Am J Med Genet 2001 105: 145–151

    Article  CAS  PubMed  Google Scholar 

  88. Gelernter J, Kranzler HR, Satel SL, Rao PA . Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia Neuropsychopharmacology 1994 11: 195–200

    Article  CAS  PubMed  Google Scholar 

  89. Persico AM, Vandenbergh DJ, Smith SS, Uhl GR . Dopamine transporter gene polymorphisms are not associated with polysubstance abuse Biol Psychiatry 1993 34: 265–267

    Article  CAS  PubMed  Google Scholar 

  90. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A et al . Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium Biol Psychiatry 1997 41: 299–304

    Article  CAS  PubMed  Google Scholar 

  91. Schmidt LG, Harms H, Kuhn S, Rommelspacher H, Sander T . Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene Am J Psychiatry 1998 155: 474–478

    Article  CAS  PubMed  Google Scholar 

  92. Sander T, Berlin W, Ostapowicz A, Samochowiec J, Gscheidel N, Hoehe MR . Variation of the genes encoding the human glutamate EAAT2, serotonin and dopamine transporters and susceptibility to idiopathic generalized epilepsy Epilepsy Res 2000 41: 75–81

    Article  CAS  PubMed  Google Scholar 

  93. Franke P, Schwab SG, Knapp M, Gansicke M, Delmo C, Zill P et al . DAT1 gene polymorphism in alcoholism: a family-based association study Biol Psychiatry 1999 45: 652–654

    Article  CAS  PubMed  Google Scholar 

  94. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG et al . Genotype influences in vivo dopamine transporter availability in human striatum Neuropsychopharmacology 2000 22: 133–139

    Article  CAS  PubMed  Google Scholar 

  95. Muramatsu T, Higuchi S . Dopamine transporter gene polymorphism and alcoholism Biochem Biophys Res Commun 1995 211: 28–32

    Article  CAS  PubMed  Google Scholar 

  96. Manki H, Kanba S, Muramatsu T, Higuchi S, Suzuki E, Matsushita S et al . Dopamine D2, D3 and D4 receptor and transporter gene polymorphisms and mood disorders J Affect Disord 1996 40: 7–13

    Article  CAS  PubMed  Google Scholar 

  97. Frisch A, Postilnick D, Rockah R, Michaelovsky E, Postilnick S, Birman E et al . Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways Mol Psychiatry 1999 4: 389–392

    Article  CAS  PubMed  Google Scholar 

  98. Waldman ID, Robinson BF, Feigon SA . Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity Genet Epidemiol 1997 14: 699–704

    Article  CAS  PubMed  Google Scholar 

  99. Kelsoe JR, Sadovnick AD, Kristbjarnarson H, Bergesch P, Mroczkowski-Parker Z, Drennan M et al . Possible locus for bipolar disorder near the dopamine transporter on chromosome 5 Am J Med Genet 1996 67: 533–540

    Article  CAS  PubMed  Google Scholar 

  100. Kirov G, Jones I, McCandless F, Craddock N, Owen MJ . Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5 Mol Psychiatry 1999 4: 558–565

    Article  CAS  PubMed  Google Scholar 

  101. Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S et al . Dopamine genes and ADHD Neurosci Biobehav Rev 2000 24: 21–25

    Article  CAS  PubMed  Google Scholar 

  102. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ . Dopamine transporter density in patients with attention deficit hyperactivity disorder [letter] Lancet 1999 354: 2132–2133

    Article  CAS  PubMed  Google Scholar 

  103. Dresel S, Krause J, Krause KH, LaFougere C, Brinkbaumer K, Kung HF et al . Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment Eur J Nucl Med 2000 27: 1518–1524

    Article  CAS  PubMed  Google Scholar 

  104. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K . Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography Neurosci Lett 2000 285: 107–110

    Article  CAS  PubMed  Google Scholar 

  105. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL . Association of attention-deficit disorder and the dopamine transporter gene Am J Hum Genet 1995 56: 993–998

    CAS  PubMed  PubMed Central  Google Scholar 

  106. Daly G, Hawi Z, Fitzgerald M, Gill M . Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children Mol Psychiatry 1999 4: 192–196

    Article  CAS  PubMed  Google Scholar 

  107. Curran S et al . Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples Mol Psychiatry 2001 6: 425–428

    Article  CAS  PubMed  Google Scholar 

  108. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M . Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism Mol Psychiatry 1997 2: 311–313

    Article  CAS  PubMed  Google Scholar 

  109. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL et al . Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity Am J Hum Genet 1998 63: 1767–1776

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL et al . A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder Mol Psychiatry 2000 5: 523–530

    Article  CAS  PubMed  Google Scholar 

  111. Roman T, Schmitz M, Polanczyk G, Eizirik M, Rohde LA, Hutz MH . Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene Am J Med Genet 2001 105: 471–478

    Article  CAS  PubMed  Google Scholar 

  112. Winsberg BG, Comings DE . Association of the dopamine transporter gene (DAT1) with poor methylphenidate response J Am Acad Child Adolesc Psychiatry 1999 38: 1474–1477

    Article  CAS  PubMed  Google Scholar 

  113. Barr CL et al . Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder Biol Psychiatry 2001 49: 333–339

    Article  CAS  PubMed  Google Scholar 

  114. Mercier G, Turpin JC, Lucotte G . Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: no association found J Neurol 1999 246: 45–47

    Article  CAS  PubMed  Google Scholar 

  115. Le Couteur DG, Leighton PW, McCann SJ, Pond S . Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease Mov Disord 1997 12: 760–763

    Article  CAS  PubMed  Google Scholar 

  116. Kislauskis EH, Li Z, Singer RH, Taneja KL . Isoform-specific 3′-untranslated sequences sort alpha-cardiac and beta-cytoplasmic actin messenger RNAs to different cytoplasmic compartments [published erratum appears in J Cell Biol 1993; 123: following 1907] J Cell Biol 1993 123: 165–172

    Article  CAS  PubMed  Google Scholar 

  117. Dix DJ, Lin PN, McKenzie AR, Walden WE, Theil EC . The influence of the base-paired flanking region on structure and function of the ferritin mRNA iron regulatory element J Mol Biol 1993 231: 230–240

    Article  CAS  PubMed  Google Scholar 

  118. Schiavi SC, Wellington CL, Shyu AB, Chen CY, Greenberg ME, Belasco JG . Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translation J Biol Chem 1994 269: 3441–3448

    CAS  PubMed  Google Scholar 

  119. Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP . The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons J Neurochem 2001 79: 1033–1038

    Article  CAS  PubMed  Google Scholar 

  120. Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, Gelernter J . Prediction of dopamine transporter binding availability by genotype: a preliminary report Am J Psychiatry 2000 157: 1700–1703

    Article  CAS  PubMed  Google Scholar 

  121. Martinez D, Gelernter J, Abi-Dargham A, van Dyck CH, Kegeles L, Innis RB, Laruelle M . The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans Neuropsychopharmacology 2001 24: 553–560

    Article  CAS  PubMed  Google Scholar 

  122. Laine TP, Ahonen A, Torniainen P, Heikkila J, Pyhtinen J, Rasanen P et al . Dopamine transporters increase in human brain after alcohol withdrawal Mol Psychiatry 1999 4: 189–191

    Article  CAS  PubMed  Google Scholar 

  123. Gelernter J, Freimer M . PstI RFLP at the SERT locus Hum Mol Genet 1994 3: 383

    Article  CAS  PubMed  Google Scholar 

  124. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP . Allelic variation of human serotonin transporter gene expression J Neurochem 1996 66: 2621–2624

    Article  CAS  PubMed  Google Scholar 

  125. Delbruck SJ, Wendel B, Grunewald I, Sander T, Morris-Rosendahl D, Crocq MA et al . A novel allelic variant of the human serotonin transporter gene regulatory polymorphism Cytogenet Cell Genet 1997 79: 214–220

    Article  CAS  PubMed  Google Scholar 

  126. Gelernter J, Kranzler H, Cubells JF . Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects Hum Genet 1997 101: 243–246

    Article  CAS  PubMed  Google Scholar 

  127. Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK . Population studies of polymorphisms of the serotonin transporter protein gene Am J Med Genet 1999 88: 61–66

    Article  CAS  PubMed  Google Scholar 

  128. Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T et al . Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder Mol Psychiatry 1997 2: 457–462

    Article  CAS  PubMed  Google Scholar 

  129. Michaelovsky E, Frisch A, Rockah R, Peleg L, Magal N, Shohat M, Weizman R . A novel allele in the promoter region of the human serotonin transporter gene Mol Psychiatry 1999 4: 97–99

    Article  CAS  PubMed  Google Scholar 

  130. Nakamura M, Ueno S, Sano A, Tanabe H . The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants Mol Psychiatry 2000 5: 32–38

    Article  CAS  PubMed  Google Scholar 

  131. Heils A, Mossner R, Lesch KP . The human serotonin transporter gene polymorphism—basic research and clinical implications J Neural Transm 1997 104: 1005–1014

    Article  CAS  PubMed  Google Scholar 

  132. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al . Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 1996 274: 1527–1531

    Article  CAS  PubMed  Google Scholar 

  133. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL . Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets Am J Med Genet 1999 88: 83–87

    Article  CAS  PubMed  Google Scholar 

  134. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F et al . Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension J Clin Invest 2001 108: 1141–1150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Willeit M, Stastny J, Pirker W, Praschak-Rieder N, Neumeister A, Asenbaum S et al . No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism Biol Psychiatry 2001 50: 8–12

    Article  CAS  PubMed  Google Scholar 

  136. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P . Organization of the human serotonin transporter gene J Neural Transm Gen Sect 1994 95: 157–162

    Article  CAS  PubMed  Google Scholar 

  137. MacKenzie A, Quinn J . A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo Proc Natl Acad Sci USA 1999 96: 15251–15255

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  138. Fiskerstrand CE, Lovejoy EA, Quinn JP . An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells FEBS Lett 1999 458: 171–174

    Article  CAS  PubMed  Google Scholar 

  139. Mortensen OV, Thomassen M, Larsen MB, Whittemore SR, Wiborg O . Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells Brain Res Mol Brain Res 1999 68: 141–148

    Article  CAS  PubMed  Google Scholar 

  140. Flattem NL, Blakely RD . Modified structure of the human serotonin transporter promoter Mol Psychiatry 2000 5: 110–115

    Article  CAS  PubMed  Google Scholar 

  141. Lesch KP, Jatzke S, Meyer J, Stober G, Okladnova O, Mossner R, Riederer P . Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depression J Neural Transm 1999 106: 1223–1230

    Article  CAS  PubMed  Google Scholar 

  142. Lesch KP, Gross J, Franzek E, Wolozin BL, Riederer P, Murphy DL . Primary structure of the serotonin transporter in unipolar depression and bipolar disorder Biol Psychiatry 1995 37: 215–223

    Article  CAS  PubMed  Google Scholar 

  143. Battersby S, Ogilvie AD, Blackwood DH, Shen S, Muqit MM, Muir WJ et al . Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3′ untranslated region of the human serotonin transporter gene J Neurochem 1999 72: 1384–1388

    Article  CAS  PubMed  Google Scholar 

  144. Glatt CE, DeYoung JA, Delgado S, Service SK, Giacomini KM, Edwards RH et al . Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes Nat Genet 2001 27: 435–438

    Article  CAS  PubMed  Google Scholar 

  145. Nakamura T, Muramatsu T, Ono Y, Matsushita S, Higuchi S, Mizushima H et al . Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese Am J Med Genet 1997 74: 544–545

    Article  CAS  PubMed  Google Scholar 

  146. Ball D, Hill L, Freeman B, Eley TC, Strelau J, Riemann R et al . The serotonin transporter gene and peer-rated neuroticism Neuroreport 1997 8: 1301–1304

    Article  CAS  PubMed  Google Scholar 

  147. Deary IJ, Battersby S, Whiteman MC, Connor JM, Fowkes FG, Harmar A . Neuroticism and polymorphisms in the serotonin transporter gene Psychol Med 1999 29: 735–739

    Article  CAS  PubMed  Google Scholar 

  148. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH . No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance Mol Psychiatry 1997 2: 224–226

    Article  CAS  PubMed  Google Scholar 

  149. Flory JD, Manuck SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF . Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism Mol Psychiatry 1999 4: 93–96

    Article  CAS  PubMed  Google Scholar 

  150. Jorm AF, Henderson AS, Jacomb PA, Christensen H, Korten AE, Rodgers B et al . An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms Mol Psychiatry 1998 3: 449–451

    Article  CAS  PubMed  Google Scholar 

  151. Osher Y, Hamer D, Benjamin J . Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs Mol Psychiatry 2000 5: 216–219

    Article  CAS  PubMed  Google Scholar 

  152. Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J et al . Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample Am J Med Genet 2000 96: 202–216

    Article  CAS  PubMed  Google Scholar 

  153. Harmar AJ, Ogilvie AD, Battersby S, Smith CA, Blackwood DH, Muir WJ et al . The serotonin transporter gene and affective disorder Cold Spring Harb Symp Quant Biol 1996 61: 791–795

    Article  CAS  PubMed  Google Scholar 

  154. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, Smith CA . Polymorphism in serotonin transporter gene associated with susceptibility to major depression Lancet 1996 347: 731–733

    Article  CAS  PubMed  Google Scholar 

  155. Stöber G, Heils A, Lesch KP . Serotonin transporter gene polymorphism and affective disorder [letter; comment] Lancet 1996 347: 1340–1341

    Article  PubMed  Google Scholar 

  156. Hoehe MR, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Rosendahl D et al . Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders Am J Med Genet 1998 81: 1–3

    Article  CAS  PubMed  Google Scholar 

  157. Saleem Q, Ganesh S, Vijaykumar M, Reddy YC, Brahmachari SK, Jain S . Association analysis of 5HT transporter gene in bipolar disorder in the Indian population Am J Med Genet 2000 96: 170–172

    Article  CAS  PubMed  Google Scholar 

  158. Collier DA et al . The serotonin transporter is a potential susceptibility factor for bipolar affective disorder Neuroreport 1996 7: 1675–1679

    Article  CAS  PubMed  Google Scholar 

  159. Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES et al . Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders Am J Med Genet 1998 81: 58–63

    Article  CAS  PubMed  Google Scholar 

  160. Esterling LE, Yoshikawa T, Turner G, Badner JA, Bengel D, Gershon ES et al . Serotonin transporter (5-HTT) gene and bipolar affective disorder Am J Med Genet 1998 81: 37–40

    Article  CAS  PubMed  Google Scholar 

  161. Mundo E, Walker M, Tims H, Macciardi F, Kennedy JL . Lack of linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and bipolar disorder Am J Med Genet 2000 96: 379–383

    Article  CAS  PubMed  Google Scholar 

  162. Mynett-Johnson L, Kealey C, Claffey E, Curtis D, Bouchier-Hayes L, Powell C, McKeon P . Multimarker haplotypes within the serotonin transporter gene suggest evidence of an association with bipolar disorder Am J Med Genet 2000 96: 845–849

    Article  CAS  PubMed  Google Scholar 

  163. Collier DA et al . A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders Mol Psychiatry 1996 1: 453–460

    CAS  PubMed  Google Scholar 

  164. Gutierrez B, Pintor L, Gasto C, Rosa A, Bertranpetit J, Vieta E, Fananas L . Variability in the serotonin transporter gene and increased risk for major depression with melancholia Hum Genet 1998 103: 319–322

    Article  CAS  PubMed  Google Scholar 

  165. Rosenthal NE, Mazzanti CM, Barnett RL, Hardin TA, Turner EH, Lam GK et al . Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder Mol Psychiatry 1998 3: 175–177

    Article  CAS  PubMed  Google Scholar 

  166. Minov C, Baghai TC, Schule C, Zwanzger P, Schwarz MJ, Zill P et al . Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression Neurosci Lett 2001 303: 119–122

    Article  CAS  PubMed  Google Scholar 

  167. Seretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E . Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders Mol Psychiatry 1999 4: 280–283

    Article  CAS  PubMed  Google Scholar 

  168. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M . Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamin Mol Psychiatry 1998 3: 508–511

    Article  CAS  PubMed  Google Scholar 

  169. Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E . Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene J Clin Psychopharmacol 2000 20: 105–107

    Article  CAS  PubMed  Google Scholar 

  170. Zanardi R, Serretti A, Rossini D, Franchini L, Cusin C, Lattuada E et al . Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-httlpr in delusional and nondelusional depression Biol Psychiatry 2001 50: 323–330

    Article  CAS  PubMed  Google Scholar 

  171. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA et al . Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression Neuropsychopharmacology 2000 23: 587–590

    Article  CAS  PubMed  Google Scholar 

  172. Mundo E, Walker M, Cate T, Macciardi F, Kennedy JL . The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings Arch Gen Psychiatry 2001 58: 539–544

    Article  CAS  PubMed  Google Scholar 

  173. Gorwood P, Batel P, Ades J, Hamon M, Boni C . Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior Biol Psychiatry 2000 48: 259–264

    Article  CAS  PubMed  Google Scholar 

  174. Russ MJ, Lachman HM, Kashdan T, Saito T, Bajmakovic-Kacila S . Analysis of catechol-O-methyltransferase and 5-hydroxytryptamine transporter polymorphisms in patients at risk for suicide Psychiatry Res 2000 93: 73–78

    Article  CAS  PubMed  Google Scholar 

  175. Fitch D, Lesage A, Seguin M, Trousignant M, Bankelfat C, Rouleau GA, Turecki G . Suicide and the serotonin transporter gene Mol Psychiatry 2001 6: 127–128

    Article  CAS  PubMed  Google Scholar 

  176. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM et al . A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide Arch Gen Psychiatry 2000 57: 729–738

    Article  CAS  PubMed  Google Scholar 

  177. Evans J, Battersby S, Ogilvie AD, Smith CA, Harmar AJ, Nutt DJ, Goodwin GM . Association of short alleles of a VNTR of the serotonin transporter gene with anxiety symptoms in patients presenting after deliberate self harm Neuropharmacology 1997 36: 439–443

    Article  CAS  PubMed  Google Scholar 

  178. Hammoumi S, Payen A, Favre JD, Balmes JL, Benard JY, Husson M et al . Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence? Alcohol 1999 17: 107–112

    Article  CAS  PubMed  Google Scholar 

  179. Thompson MD, Gonzalez N, Nguyen T, Comings DE, George SR, O'Dowd BF . Serotonin transporter gene polymorphisms in alcohol dependence Alcohol 2000 22: 61–67

    Article  CAS  PubMed  Google Scholar 

  180. Sander T, Harms H, Lesch KP, Dufeu P, Kuhn S, Hoehe M et al . Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence Alcohol Clin Exp Res 1997 21: 1356–1359

    Article  CAS  PubMed  Google Scholar 

  181. Matsushita S, Yoshino A, Murayama M, Kimura M, Muramatsu T, Higuchi S . Association study of serotonin transporter gene regulatory region polymorphism and alcoholism Am J Med Genet 2001 105: 446–450

    Article  CAS  PubMed  Google Scholar 

  182. Schuckit MA, Mazzanti C, Smith TL, Ahmed U, Radel M, Iwata N, Goldman D . Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study Biol Psychiatry 1999 45: 647–651

    Article  CAS  PubMed  Google Scholar 

  183. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR et al . Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels Am J Psychiatry 1998 155: 207–213

    Article  CAS  PubMed  Google Scholar 

  184. Heinz A, Jones DW, Mazzanti C, Goldman D, Ragan P, Hommer D et al . A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity Biol Psychiatry 2000 47: 643–649

    Article  CAS  PubMed  Google Scholar 

  185. Cloninger CR . Neurogenetic adaptive mechanisms in alcoholism Science 1987 236: 410–416

    Article  CAS  PubMed  Google Scholar 

  186. Sander T, Harms H, Dufeu P, Kuhn S, Hoehe M, Lesch KP et al . Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder Biol Psychiatry 1998 43: 908–912

    Article  CAS  PubMed  Google Scholar 

  187. Hallikainen T, Saito T, Lachman HM, Volavka J, Pohjalainen T, Ryynanen OP et al . Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior Mol Psychiatry 1999 4: 385–388

    Article  CAS  PubMed  Google Scholar 

  188. Preuss UW, Soyka M, Bahlmann M, Wenzel K, Behrens S, de Jonge S et al . Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity Psychiatry Res 2000 96: 51–61

    Article  CAS  PubMed  Google Scholar 

  189. Bondy B, Erfurth A, de Jonge S, Kruger M, Meyer H . Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide Mol Psychiatry 2000 5: 193–195

    Article  CAS  PubMed  Google Scholar 

  190. Courtet P, Baud P, Abbar M, Boulenger JP, Castelnau D, Mouthon D et al . Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene Mol Psychiatry 2001 6: 338–341

    Article  CAS  PubMed  Google Scholar 

  191. Zhong N, Ye L, Ju W, Brown WT, Tsiouris J, Cohen I . 5-HTTLPR variants not associated with autistic spectrum disorders Neurogenetics 1999 2: 129–131

    Article  CAS  PubMed  Google Scholar 

  192. Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A et al . Evidence of linkage between the serotonin transporter and autistic disorder Mol Psychiatry 1997 2: 247–250

    Article  PubMed  Google Scholar 

  193. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A . Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 1997 6: 2233–2238

    Article  CAS  PubMed  Google Scholar 

  194. Yirmiya N, Pilowsky T, Nemanov L, Arbelle S, Feinsilver T, Fried I, Ebstein RP . Evidence for an association with the serotonin transporter promoter region polymorphism and autism Am J Med Genet 2001 105: 381–386

    Article  CAS  PubMed  Google Scholar 

  195. Tordjman S, Gutknecht L, Carlier M, Spitz E, Antoine C, Slama F et al . Role of the serotonin transporter gene in the behavioral expression of autism Mol Psychiatry 2001 6: 434–439

    Article  CAS  PubMed  Google Scholar 

  196. (IMGSAC) IMGSoAC. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p Am J Hum Genet 2001 69: 570–581

    Article  Google Scholar 

  197. Morison IM, Reeve AE . A catalogue of imprinted genes and parent-of-origin effects in humans and animals Hum Mol Genet 1998 7: 1599–1609

    Article  CAS  PubMed  Google Scholar 

  198. Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q, Murphy DL . Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder Mol Psychiatry 1999 4: 463–466

    Article  CAS  PubMed  Google Scholar 

  199. McDougle CJ, Epperson CN, Price LH, Gelernter J . Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder Mol Psychiatry 1998 3: 270–273

    Article  CAS  PubMed  Google Scholar 

  200. Hanna GL, Himle JA, Curtis GC, Koram DQ, Veenstra-VanderWeele J, Leventhal BL, Cook EH Jr . Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder Neuropsychopharmacology 1998 18: 102–111

    Article  CAS  PubMed  Google Scholar 

  201. Billett EA, Richter MA, King N, Heils A, Lesch KP, Kennedy JL . Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene Mol Psychiatry 1997 2: 403–406

    Article  CAS  PubMed  Google Scholar 

  202. Altemus M, Murphy DL, Greenberg B, Lesch KP . Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder Am J Med Genet 1996 67: 409–411

    Article  CAS  PubMed  Google Scholar 

  203. Biederman J, Spencer T . Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder Biol Psychiatry 1999 46: 1234–1242

    Article  CAS  PubMed  Google Scholar 

  204. Hardman JG, Limbirb LE (eds) . Goodman and Gilman's The Pharmacological Basis of Therapeutics McGraw Hill: New York 2001

    Google Scholar 

  205. Watling KJ, Kebabian JW, Neumeyer JL (eds) . The RBI Handbook of Receptor Classification and Signal Transduction Research Biochemicals International: Natick 1995

    Google Scholar 

  206. Rubie C, Schmidt F, Knapp M, Sprandel J, Wiegand C, Meyer J et al . The human dopamine transporter gene: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample Neurosci Lett 2001 297: 125–128

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Center for Molecular Neuroscience, Vanderbilt University, Nashville, TN, USA

    M K Hahn & R D Blakely

Authors
  1. M K Hahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R D Blakely
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M K Hahn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hahn, M., Blakely, R. Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders. Pharmacogenomics J 2, 217–235 (2002). https://doi.org/10.1038/sj.tpj.6500106

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.tpj.6500106

Keywords

This article is cited by

Search

Advanced search

Quick links